TK
Takara Bio Inc.
TKBIF · OTC
$7.30 +0.00% (+$0.00)
Market Cap $879.0M
P/E Ratio -
Div. Yield -
ROE 9.37%
Valuation
34 /100
Fair P/S 3.32x
P/B 1.35x
EV/EBITDA 206.30x
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 24.20%
Op. margin 11.75%
FCF margin 22.85%
Quality
4 /100
Poor ROE 9.37%
ROA 7.62%
Asset turnover 0.31x
Debt
80 /100
Low Current ratio 5.76x
Int. coverage -8.17x
Net debt/EBITDA -15.01x
Stability
58 /100
Moderate Beta 0.43x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TKBIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tsuyoshi Miyamura
Employees
1,838
Headquarters
Kusatsu